AdvanCell
Changing the Course of Cancer Treatment
Sydney, Australia · Founded 2019 · $427.0M raised
- Headquarters
- Sydney
- Employees
- 11–50
- Founded
- 2019
- Business Model
- B2B
- Website
- advancell.com.au
- Total Funding
- $427.0M
- Last Round
- $315.0M Venture RoundJul 2026
- Rounds
- 2
About
AdvanCell is a clinical-stage radiopharmaceutical company developing targeted alpha therapies for cancer using lead-212 (212Pb). Headquartered in Sydney, Australia with a growing US presence, the company operates a vertically integrated platform for manufacturing and delivering 212Pb-based therapies, with a lead program targeting PSMA for prostate cancer.
Summary
AdvanCell is a Biotech company based in Sydney, Australia, founded in 2019. It has raised $427.0M in total across 2 rounds, most recently a $315.0M Venture Round round in Jul 2026.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Jul 2026
Sign up to see all 2 rounds
Series C through Venture Round — per-round amounts, valuations, and who invested in each round.
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/advancel"><img src="https://indexed.vc/api/badge/company/advancel" alt="AdvanCell on Indexed.vc" width="260" height="76" /></a>